Mylan Hit With IP Suit Over Generic Cholesterol Drug
Kowa Company Ltd. on Thursday sued Mylan Inc. in Pennsylvania federal court, claiming Mylan's application to market a generic version of the cholesterol-lowering drug Livalo violates three of Kowa's patents....To view the full article, register now.
Already a subscriber? Click here to view full article